Celgene Corp (NASDAQ:CELG)

CAPS Rating: 5 out of 5

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

Recs

0
Player Avatar 1badbeerad (32.48) Submitted: 11/12/2012 2:58:45 PM : Outperform Start Price: $37.47 CELG Score: +25.43

Running gunning.

Featured Broker Partners


Advertisement